Centre for Rare Diseases and Personalised Medicine, Department of Medical and Molecular Genetics, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Am J Med Genet A. 2013 Feb;161A(2):338-42. doi: 10.1002/ajmg.a.35712. Epub 2013 Jan 15.
Aicardi-Goutières syndrome (AGS) is an encephalopathy of early childhood which is most commonly inherited as an autosomal recessive trait. The disorder demonstrates significant genetic heterogeneity with causative mutations in five genes identified to date. Although most patients with AGS experience a severe neonatal or infantile presentation, poor neurodevelopmental outcome and reduced survival, clinical variability in the onset and severity of the condition is being increasingly recognized. A later presentation with a more variable effect on development, morbidity and mortality has been particularly observed in association with mutations in SAMHD1 and RNASEH2B. In contrast, the recurrent c.205C > T (p.R69W) RNASEH2C Asian founder mutation has previously only been identified in children with a severe AGS phenotype. Here, to our knowledge, we present the first report of marked phenotypic variability in siblings both harboring this founder mutation in the homozygous state. In this family, one female child had a severe AGS phenotype with an onset in infancy and profound developmental delay, whilst an older sister was of completely normal intellect with a normal head circumference and was only diagnosed because of the presence of chilblains and a mild hemiplegia. An appreciation of intrafamilial phenotypic expression is important in the counseling of families considering prenatal diagnosis, and may also be relevant to the assessment of efficacy in future clinical trials. In addition, marked phenotypic variation raises the possibility that more mildly affected patients are not currently identified.
Aicardi-Goutières 综合征(AGS)是一种儿童期脑病,最常见的遗传方式为常染色体隐性遗传。该疾病表现出明显的遗传异质性,迄今为止已确定了五个致病基因突变。尽管大多数 AGS 患者表现为严重的新生儿或婴儿期起病、不良的神经发育结局和存活率降低,但该疾病的发病和严重程度的临床变异性正日益受到关注。越来越多的患者表现为发病晚、对发育、发病率和死亡率的影响更具变异性,这与 SAMHD1 和 RNASEH2B 基因突变有关。相比之下,先前仅在具有严重 AGS 表型的儿童中发现了 RNASEH2C 基因 c.205C > T(p.R69W)的反复出现的亚洲突变。在此,据我们所知,我们首次报道了这一突变纯合状态的同一家系中两个同胞存在明显的表型变异性。在这个家庭中,一名女性患儿具有严重的 AGS 表型,在婴儿期起病且存在严重的发育迟缓,而其年龄较大的姐姐智力完全正常、头围正常,仅因出现冻疮和轻度偏瘫而被诊断。对于考虑产前诊断的家庭,了解家族内的表型表达非常重要,这可能也与未来临床试验中疗效评估相关。此外,明显的表型变异提示目前可能还有病情较轻的患者未被发现。